Suchergebnisse - "Folkerts, Kerstin"

PubPharm (26)

1

Heart failure with mildly reduced and preserved ejection fraction : A review of disease burden and remaining unmet medical needs within a new treatment landscape

enthalten in: Heart failure reviews | 2024

von Desai, N. | Olewinska, E. | Famulska, A. | +3

2

Heart failure with mildly reduced and preserved ejection fraction: A review of disease burden and remaining unmet medical needs within a new treatment landscape

enthalten in: Heart failure reviews | 2024

von Desai, N. | Olewinska, E. | Famulska, A. | +3

3

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease

enthalten in: Journal of nephrology | 2023

von Folkerts, K. | Millier, A. | Smela, B. | +4

4

High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes : real-world evidence from a US claims database

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023

von Fried, L. | Schmedt, N. | Folkerts, K. | +4

5

Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes

enthalten in: Journal of medical economics | 2023

von Rossing, P. | Groehl, F. | Mernagh, P. | +8

ErratumIn: J Med Econ. 2023 Jan-Dec;26(1):1032-1033. - PMID 37587878

6

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease

enthalten in: Journal of nephrology | 2022

von Folkerts, K. | Millier, A. | Smela, B. | +4

7

Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes

enthalten in: The American journal of managed care | 2022

von Pochopień, M. | Cherney, D. | Drzewiecka, A. | +8

8

Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors

enthalten in: BMC medicine | 2022

von Kovesdy, C. | Schmedt, N. | Folkerts, K. | +4

9

Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors

enthalten in: BMC medicine | 2022

von Kovesdy, C. | Schmedt, N. | Folkerts, K. | +4

10

Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors

enthalten in: BMC medicine | 2022

von Kovesdy, C. | Schmedt, N. | Folkerts, K. | +4